BEIJING/HONG KONG, April 20 - When Pang Jianli walked into a Beijing pharmacy to buy medicine for his flu-stricken son, he was greeted by an overwhelming display of boxes and bottles emblazoned with promises of...
BEIJING/HONG KONG, April 20 - When Pang Jianli walked into a Beijing pharmacy to buy medicine for his flu-stricken son, he was greeted by an overwhelming display of boxes and bottles emblazoned with promises of...
BEIJING/HONG KONG, April 20 - When Pang Jianli walked into a Beijing pharmacy to buy medicine for his flu-stricken son, he was greeted by an overwhelming display of boxes and bottles emblazoned with promises of...
SHANGHAI, Nov 19 - Fosun International Ltd <0656.HK>, China's largest non-state conglomerate, plans to expand investment in pharmaceutical and consumer-related businesses in the next few years as the government encourages domestic consumption, C...
ORLANDO, Fla., Nov 17 - An experimental drug for patients genetically disposed to extreme high cholesterol being developed by Isis Pharmaceuticals Inc and Genzyme Corp significantly lowered cholesterol in a pivotal late-stage study, according to...
OSAKA, Japan, Nov 17 - Japan's No. 1 generic drug maker, Sawai Pharmaceutical, aims to lift its share of the growing domestic market despite competition from bigger foreign players and a headwind from government price...
* Drug seen having blockbuster potential - analysts * Lung cancer trial results not to impact other studies * Acquisition a possibility on both events BANGALORE, Nov 13 - Results from Poniard Pharmaceuticals Inc's late-stage...
World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia...
WASHINGTON, Nov 12 - The U.S. Justice Department plans to focus on prosecuting those in the pharmaceutical industry who try to bribe foreign officials for preferential treatment of their products, a senior official said on...
NEW YORK, Nov 9 - Novartis AG's <NOVN.VX> drugs unit will continue to outgrow a sickly overall pharmaceuticals market, driven by new treatments for cancer, multiple sclerosis and lung disease, its divisional chief said on...